Author:
Lim Young Chai,Desta Zeruesenay,Flockhart David A.,Skaar Todd C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference42 articles.
1. Allan GF, Hutchins A, Liu X, Clancy J (2001) Induction of the progesterone receptor gene in estrogen target cells monitored by branched DNA signal amplification. Steroids 66:663?671
2. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21:1973?1979
3. Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91:1654?1662
4. Bethea CL, Widmann AA (1998) Differential expression of progestin receptor isoforms in the hypothalamus, pituitary, and endometrium of rhesus macaques. Endocrinology 139:677?687
5. Bonomi P, Gale M, Von Roenn J, Anderson K, Johnson P, Wolter J, Economou S (1988) Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Semin Oncol 15:26?33
Cited by
251 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献